Docteur Maëlle LE GOFF
✨ Profil synthétique
IA · 30/04/2026Le Docteur Maëlle LE GOFF est rhumatologue à Nantes, exerçant dans un cadre hospitalier. Ses publications sur PubMed révèlent une implication dans la recherche sur la gériatrie et la maladie de Sjögren. Ces travaux suggèrent une expertise dans la prise en charge de pathologies rhumatismales complexes, notamment chez les patients âgés.
Expertises présumées
- Gériatrie
- Maladie de Sjögren
- Rhumatologie gériatrique
- Pathologies auto-immunes
- Système immunitaire sénile
- Rhumatisme chez les personnes âgées
- Sjögren primaire et secondaire
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
📝 Autres formations
- Pathologie infectieuse et tropicale, clinique et biologique
- Pathologie infectieuse et tropicale, clinique et biologique (DNQ)
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Bibliographie
Réforme du 3e cycle et DES de Maladies Infectieuses et Tropicales : quel bilan? Une enquête transversale nationale
2025ArticleMédecine et Maladies Infectieuses Formation
Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients
2022ArticleClinical Infectious Diseases
Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei
2019ArticlePLoS ONE
Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren’s syndrome
2017ArticleArthritis Research and Therapy
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Lieu de consultation
CHU DE NANTES SITE HOTEL DIEU HME
1 Place ALEXIS RICORDEAU, 44093 Nantes
Tarifs & secteur de conventionnement
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 2Co-Occurrence of Geriatric Syndromes and Diseases in the General Population: Assessment of the Dimensions of Aging
The journal of nutrition, health & aging · 2022
- 3Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
📚 8 citations🎯 RCR 1.37Lire l'abstract Crossref ↓
Abstract Background The impact of chemoprophylaxis targeting Plasmodium falciparum on Plasmodium vivax and Plasmodium ovale, which may remain quiescent as hypnozoites in the liver, is debated. Methods We conducted a nested case-control analysis of the outcomes of P. vivax and P. ovale infections in imported malaria cases in France among civilian travelers from 1 January 2006, to 31 December 2017. Using adjusted logistic regression, we assessed the effect of chemoprophylaxis on the incubation period, time from symptoms to diagnosis, management, blood results, symptoms, and hospitalization duration. We analyzed the effect of blood-stage drugs (doxycycline, mefloquine, chloroquine, chloroquine-proguanil) or atovaquone-proguanil on the incubation period. We used a counterfactual approach to ascertain the causal effect of chemoprophylaxis on postinfection characteristics. Results Among 247 P. vivax– and 615 P. ovale–infected travelers, 30% and 47%, respectively, used chemoprophylaxis, and 7 (3%) and 8 (1%) were severe cases. Chemoprophylaxis users had a greater risk of presenting symptoms >2 months after returning for both species (P. vivax odds ratio [OR], 2.91 [95% confidence interval {CI}, 1.22–6.95], P = .02; P. ovale OR, 2.28 [95% CI, 1.47–3.53], P < .001). Using drugs only acting on the blood stage was associated with delayed symptom onset after 60 days, while using atovaquone-proguanil was not. Conclusions Civilian travelers infected with P. vivax or P. ovale reporting chemoprophylaxis use, especially of blood-stage agents, had a greater risk of delayed onset of illness. The impact of chemoprophylaxis on the outcomes of infection with relapse-causing species calls for new chemoprophylaxis acting against erythrocytic and liver stages.
Publications scientifiques (4) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal2
▼
Transversal2
▼- Impact of Chemoprophylaxis on Plasmodium vivax and Plasmodium ovale Infection Among Civilian Travelers: A Nested Case-Control Study With a Counterfactual Approach on 862 Patients
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · Journal Article
Le Goff M, Kendjo E, Thellier M, Piarroux R, et al.
📚 8 cit.🎯 RCR 1.37 - Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei
PloS one · 2019 · Journal Article
Le Goff M, Cornec D, Guellec D, Marhadour T, et al.
📚 3 cit.
Gériatrie1
▼
Gériatrie1
▼- Co-Occurrence of Geriatric Syndromes and Diseases in the General Population: Assessment of the Dimensions of Aging
The journal of nutrition, health & aging · 2022 · Journal Article
Dartigues JF, Le Bourdonnec K, Tabue-Teguo M, Le Goff M, et al.
📚 12 cit.🎯 RCR 1.59
Sjögren1
▼
Sjögren1
▼- Comparison of 2002 AECG and 2016 ACR/EULAR classification criteria and added value of salivary gland ultrasonography in a patient cohort with suspected primary Sjögren's syndrome
Arthritis research & therapy · 2017 · Comparative Study
Le Goff M, Cornec D, Jousse-Joulin S, Guellec D, et al.
📚 77 cit.🎯 RCR 4.14🔬→🩺 Translationnel